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158-Symp
Scaling Laws Governing Growth and Division of Single Bacterial Cells
Aaron Dinner.
Chemistry, The University of Chicago, Chicago, IL, USA.
Are there simple quantitative relationships that govern the behaviors of whole
organisms? If so, what form do they take? To address these questions, we
study growth and division of Caulobacter crescentus, a paradigm for polar
cell development and cell cycle control. Using a unique combination of tech-
nologies that yields unprecedented statistical precision, we find that their
mean sizes grow exponentially in time and that their size distributions
collapse to a single curve when rescaled by their means. An analogous result
holds for the division-time distributions. We account for these observations
with a minimal stochastic model that is based on an autocatalytic cycle. It pre-
dicts the scalings, as well as specific functional forms for the universal curves.
Our experimental and theoretical analysis reveals a simple physical principle
governing these core biological processes: a single timescale governs noisy
bacterial growth and division despite the complexity of underlying molecular
mechanisms.
159-Symp
Driving with the Brakes on: An Incoherent Transcriptional Circuit
Patterns the Drosophila Embryo
Angela DePace.
Systems Biology, Harvard University, Boston, MA, USA.
We used modeling and quantitative experiments to uncover a case where a
bifunctional transcription factor regulates the same expression pattern in oppo-
site ways. I will discuss the functional implications of this type of transcrip-
tional circuit, and how our results highlight the need for new methods to
determine how promoters integrate information from multiple enhancers.
160-Symp
Temporal Frequency of Directional Sensing and Collective Migration in
Dictyostelium
Satoshi Sawai.
Graduate School of Arts and Sciences, University of Tokyo, Tokyo, Japan.
In the social amoebae Dictyostelium discoideum, stimulation by chemoattrac-
tant cAMP invokes a transient rise in cytosolic cAMP that is secreted and excite
other cells in the neighborhood. The adaptive cAMP response is the key prop-
erty that supports the synchronized oscillations and waves of extracellular
cAMP that direct cell aggregation. Here, we report on simultaneous live-cell
observations of propagating cAMP waves, cell motion and the intracellular sig-
nals involved in the leading edge formation. We show that, for early aggrega-
tion stage, there is a good correspondence between the waves indirectly
observed by means of light-scattering and those observed by FRET cAMP in-
dicators. During the later cell streaming stage, there is a clear transition in the
oscillation frequency from about 6 to 3 minutes. The timing of this shift in peri-
odicity coincides with the onset of cell streaming - a distinct mode of cell
migration of elongated cells that are aligned and appear tightly connected
from the back of a cell to the front of another. Observations of Ras activation,
phosphatidylinositol (3,4,5)-trisphosphate (Pip3), F-actin and cytosolic cAMP
revealed that, during the 6-min cAMP oscillations, Ras, Pip3 and F-actin are
synchronized in phase with cAMP in a biphasic manner. The secondary peak
corresponds to lateral pseudopod formation observed during the resting phase
of the cAMP oscillations. In contrast, after the transition to 3-min oscillations,
lateral pseudopod formation disappears and cell migration becomes ballistic
and highly efficient. The present results suggest that these modes of cell migra-
tion are closed associated with the underlying kinetics of the directional sensing
and cell polarity.
161-Symp
The Emergence of Heart Failure as a Consequence of Myocardial
Metabolic Dysfunction
Daniel A. Beard.
Molecular and Integrative Physiology, University of Michigan, Ann Arbor,
MI, USA.
It is widely appreciated that heart failure is associated with alteration in meta-
bolic/energetic state of the myocardium. However, it remains unknown what
exactly is the nature these alterations, and if/how these changes might impactthe ability of the heart to generate pressure and pump the blood through the cir-
culation. Like many questions associated with the etiology of complex disease,
this is a chicken-or-the-egg question: To what extent does mechanical/struc-
tural remodeling precede and cause the metabolic changes observed to occur
with mechanical failure of the organ? To what extent can mechanical failure
be explained by diminished metabolic function? We developed a multi-scale
multi-physics simulation of the cardiovascular system to probe the hypothesis
that since variety of cellular processes in the heart depend critically on ATP,
alterations in ATP hydrolysis potential could result in mechanical dysfunction
at the level of the cardiac myocyte resulting in impaired contractile perfor-
mance of the heart and, ultimately, heart failure. Since heart failure is a
whole-body disease, with clinical presentation influenced by cardiac, pulmo-
nary, renal, and neurohumoral function this investigation requires an integrated
simulation spanning molecular/metabolic function to whole-body cardiovascu-
lar dynamics. Accounting for myocardial metabolism (normal versus changes
associated with heart failure), electrophysiology and calcium handling, cross-
bridge kinetics and mechanics, and neurohumoral signaling in the context of
a whole-body model of cardiovascular dynamics, simulations reveal the extent
to which the key clinical features emerge as consequences of metabolic
dysfunction at the cellular level. These theoretical predictions are validated
based on pharmacological interventions targeting key metabolic pathways in
the heart.Symposium: Protein Evolution and Allosteric
Networks
162-Symp
Understanding Enzyme Molecular Evolution toward Thermal Adaptation
using Multistate Computational Protein Design
Corey J. Wilson.
School of Engineering and Applied Science, Yale University, New Haven,
CT, USA.
A careful balance between structural-stability and flexibility (allostery) are
hallmarks of enzymatic function and temperature can affect both properties.
Canonical (fixed-backbone) enzyme design strategies currently do not
consider the role of these properties. Here we describe the rational design
of 100 temperature-adapted adenylate kinase (AdK) enzymes via a novel
multistate design strategy that takes into consideration the impact of confor-
mational changes to the backbone structure and stability, based on boundaries
set by molecular evolution. In turn, each AdK protein variant was expressed
and experimentally characterized for thermostability and temperature-adapted
function. Comparison of the experimental temperature of maximum activity to
the melting-temperature across all 100 variants reveals a strong correlation
between these two parameters. In turn, experimental stability data was used
to produce accurate predictions of thermostability via multistage nodes,
providing the requisite complement for de novo temperature-adapted enzyme
design. To the best of our knowledge the rational design of temperature
adaptive enzyme function has not been realized, prior to this work. In
principle, this level of design-based analysis can be applied to any protein,
paving the way toward identifying and understanding the hallmarks of enzy-
matic allostery as it relates to the thermodynamic and structural limits of
function.
163-Symp
Allosteric Networks in Thrombin
Elizabeth Komives.
Chem/Biochem, University California, San Diego, La Jolla, CA, USA.
Serine proteases are found ubiquitously in both eukaryotes and prokaryotes
however the dynamic motions of this largest peptidase family remains un-
known. All serine proteases have a double b-barrel core surrounded by connect-
ing loops and helices, but compared to the prototypical serine protease,
chymotrypsin, thrombin has more extended loops that are thought to
impart greater specificity. We analyzed apo-thrombin and active site-bound
(PPACK-thrombin) using a combination of MD, accelerated MD and NMR.
Community analysis of the MD ensembles identified groups of residues linked
through correlated motions and physical contacts. AMD simulations, calibrated
on measured residual dipolar couplings, revealed correlated loop motions con-
necting the active site with distal allosteric regulator binding sites. The back-
bone dynamics profile (from ps to ms motions) of thrombin was determined
in both states using R1, R2,
15N-{1H}NOEs, TROSY Hahn-Echo, and relaxa-
tion dispersion experiments. The apo thrombin backbone is highly dynamic and
shows motions across multiple time scales. The various surface loops move on
different time scales. The substrate-binding loops showed intermediate time
34a Sunday, February 8, 2015scale motions that are quenched upon PPACK binding. TROSYHahn-echo and
relaxation dispersion experiments reveal a large number of residues throughout
the protein undergoing temporally correlated ms-ms motions. These include the
Naþ-binding loop and the b-strand connecting exosite 1 and the active site,
both of which are implicated in allosteric coupling of effector binding sites
with the active site. The results show a network of slowly exchanging residues
extends through the entire apo-thrombin molecule.
164-Symp
The Evolution of Enzyme Mechanisms and Functional Diversity
Janet Thornton.
Thornton Group, European Bioinformatics Institute, Cambridge, United
Kingdom.
Enzyme activity is essential for almost all aspects of life. With completely
sequenced genomes, the full complement of enzymes in an organism can be
defined, and 3D structures have been determined for many enzyme families.
Traditionally each enzyme has been studied individually, but as more enzymes
are characterised it is now timely to revisit the molecular basis of catalysis, by
comparing different enzymes and their mechanisms, and to consider how com-
plex pathways and networks may have evolved. New approaches to understand-
ing enzymes mechanisms and how enzyme families evolve functional diversity
will be described.
1.Martinez Cuesta S, Furnham N, Rahman SA, Sillitoe I, Thornton JM. The
evolution of enzyme function in the isomerases. Current Opinion in Structural
Biology (2014), 26:121-130
2.Gemma L. Holliday, Asad Syed Rahman, Nicholas Furnham, and Janet M.
Thornton. Exploring the biological and chemical complexity of the ligases
(2014), J Mol Biol Volume 426 (2014) p.2098-2111
3. Furnham, N, Sillitoe, I, Holliday, GL, Cuff, AL, Laskowski, RA, Orengo,
CA, and Thornton, JM. Exploring the Evolution of Novel Enzyme Functions
within Structurally Defined Protein Superfamilies. 2012, PLoS Comput. Biol.
8, e1002403.
4.Rahman, Syed A., Cuesta Sergio M., FurnhamNicholas, Holliday Gemma L.,
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Myosin Myopathies
Leslie Leinwand.
Biorontiers, University of Colorado, Boulder, CO, USA.
More than 300 mutations in the b myosin heavy chain gene cause a variety of
both skeletal and cardiomyopathies. Most of these mutations are autosomal
dominant; thus most patients have both mutant and wild type myosin in their
heart and skeletal muscle. The mutations are distributed throughout the mole-
cule, including the motor domain and the a helical coiled coil rod. We hypoth-
esize that the mechanisms of pathogenesis are distinct between mutations in
these two functional domains. We have adopted a number of approaches to
define the functional impact of these mutations on myosin function. For study-
ing mutations in the motor domain, we produce recombinant human cardiac
myosin motors and carry out in vitro biochemical and biophysical analysis.
Historically, studies investigating the effects of myosin motor domain muta-
tions have been performed on a wide variety of myosins from many species
and myosin isoforms. Likely as a result of this, results have been confusing.
We have begun analyzing two mutations in the motor domain that cause hyper-
trophic cardiomyopathy (R403Q and R453C) and have found that each muta-
tion affects myosin motor function differently. To study the impact of
mutations in the rod domain, we carry out biophysical analyses on purified pro-
tein and perform live cell imaging to determine the effects of mutations on
sarcomere integrity. We have also found that myosin rod mutations that cause
Laing distal myopathy have distinct phenotypes that include accumulation into
aggregates and crystalline arrays in cells. To attempt to develop therapeutics for
such single nucleotide mutations without affecting the wild type myosin, we are
developing allele-specific silencing approaches.
166-Symp
Posttranslational Modification of Titin Domains as a Main Regulator of
Myocardial Stiffness
Wolfgang A. Linke.
Institute of Physiology, Ruhr Univ. Bochum, Bochum, Germany.
The giant protein titin is responsible for the elasticity of striated muscle cells
and engages in both mechanical and signaling functions of the heart. TTN,which encodes titin, is a major human disease gene. Mutations in the
myosin-bound part of titin account for a large share of familial cases of dilated
cardiomyopathy. The elasticity of cardiac titin, which resides in the molecule’s
I-band region, is regulated by various means, including titin-isoform switching,
phosphorylation of unique spring elements by different kinases, and oxidative
stress-related alterations to titin. In failing human hearts, titin is hypo-
phosphorylated, which appears to be due in part to a phosphorylation deficit
at the cardiac-specific N2-B unique sequence and likely contributes to a
pathologically increased (titin-based) diastolic stiffness. A recent focus has
been the regulation of the mechanical properties of the immunoglobulin-like
(Ig-)domains in the titin spring segment. New evidence suggests that a low
but non-negligible number of Ig-domains unfolds-refolds within the physiolog-
ical sarcomere-length range. These Ig-domains are targeted via an oxidative
stress-related mechanism recently identified by single-molecule AFM force
spectroscopy. If unfolded, the Ig-domains expose cryptic cysteines, which in
the presence of oxidized glutathione can become S-glutathionylated. The pres-
ence of mixed disulfide(s) with glutathione weakens the mechanical stability of
the unfolded Ig-domains and prevents their refolding, thus reducing titin stiff-
ness. Incubation of stretched (skinned) human cardiomyocytes with oxidized
glutathione significantly lowered their passive tension, and the effect was fully
reversible on incubation with a reductant. In experimental mouse hearts
exposed to oxidative stress (0.1 mM H2O2), I-band Ig-domains of titin were
identified as preferential targets of oxidation using ICAT labeling/mass spec-
trometry. These findings establish that disrupted Ig-folding-unfolding dy-
namics can cause sustained but reversible changes to titin elasticity, which
may also be relevant in heart disease.
167-Symp
MYBPC3 Gene Therapy for Neonatal Sarcomeric Cardiomyopathies
Lucie Carrier.
Experimental Pharmacology and Toxicology, University Medical Center
Hamburg-Eppendorf, Hamburg, Germany.
Hypertrophic cardiomyopathy (HCM) is mainly characterized by left ventricular
hypertrophy (LVH), diastolic dysfunction and increased interstitial fibrosis.
HCM has an estimated prevalence in a young adult population of 1:500 and is
the leading cause of sudden cardiac death in young athletes. HCM is transmitted
in an autosomal-dominant fashion and often caused by mutations in MYBPC3,
encoding cardiac myosin-binding protein C (cMyBP-C). Most MYBPC3 muta-
tions result in truncated proteins. Findings in humans and in cat/mouse models
indicate that haploinsufficiency is the most prevalent HCM mechanism. The
presence of double truncating MYBPC3 mutations in infants has been shown
to result in severe heart failure and death within 1 year. One of our goals is to
prevent the development of the severe cardiac disease phenotype by gene ther-
apy.We developed a mouse model that genetically mimics some human neonatal
forms of HCM. The Mybpc3-targeted knock-in (KI) mice carry a homozygous
G>A transition in exon 6, resulting in 3 different aberrant mRNAs and proteins.
I will present the results of the different gene therapy approaches we performed
in this mouse model, which include 50-trans-splicing, exon skipping and over-
expression. The different strategies were evaluated in isolated cardiac myo-
cytes, engineered heart tissue or in vivo in the homozygous KI mice. With
the 3 approaches, we provided proof-of-concept studies that paved the way
to evaluate the concept in larger animal models and then in severe forms of
human neonatal cardioymyopathies.
References
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168-Symp
An Integrative Approach to Thin Filament Cardiomyopathies: From
Molecular and Computational Biophysics to Mice
Jil Tardiff.
University of Arizona, Tucson, AZ, USA.
In many ways, sarcomeric cardiomyopathies represent the most ‘‘biophysi-
cal’’ of disorders in that many of the known mutations, especially those linked
to the components of the regulatory thin filament alter the biophysical prop-
erties of the sarcomere, leading to a complex and often severe human cardio-
myopathy. Despite extensive research, developing robust mechanistic links
between sarcomeric dysfunction caused by independent mutations and cardiac
performance has proven surprisingly elusive. On the biophysical side of the
question, newer approaches including computation and structural methodolo-
gies performed on fully reconstituted systems now provide more resolution
into the inherently dynamic, allosteric effects of mutations on the sarcomeric
machinery. On the clinical side, in recent years it has become clear that the
